AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Medicenna Therapeutics Corp.

CAD 0.42 -$0.58 (-58.00%)
TSX · 14 Sep 2026 19:54 UTC
Previous Close
CAD 0.41
Day Range
CAD 0.41CAD 0.43
Year Range
CAD 0.34CAD 1.97
Market Cap
32.6M
AVG Volume
89.41K
Trailing/Forward PE
-1.91/-
PEG ratio
0.04
Dividend Yield
-
Next Earnings Date
2026-11-12
Primary Exchange
Toronto Stock ExchangeCA
Revenue (CAD)
02K4K6K24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDNA.TO Revenue (CAD) by quarter
PeriodRevenue (CAD)
27 Q10
26 Q40
26 Q30
26 Q20
26 Q10
25 Q40
25 Q30
25 Q20
25 Q15K
24 Q40
Net Income (CAD)
-15M-10M-5M05M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDNA.TO Net Income (CAD) by quarter
PeriodNet Income (CAD)
27 Q1-5.08M
26 Q4-4.23M
26 Q3-4.36M
26 Q2-4.88M
26 Q1-4.93M
25 Q41.19M
25 Q3-5.19M
25 Q2-4.16M
25 Q1-3.64M
24 Q4-13.9M
Operating Income (CAD)
-8M-6M-4M-2M024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDNA.TO Operating Income (CAD) by quarter
PeriodOperating Income (CAD)
27 Q1-5.45M
26 Q4-7.12M
26 Q3-5.62M
26 Q2-5.47M
26 Q1-5.51M
25 Q4-5.72M
25 Q3-5.12M
25 Q2-5.53M
25 Q1-4.04M
24 Q4-4M
EBITDA (CAD)
-8M-6M-4M-2M024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDNA.TO EBITDA (CAD) by quarter
PeriodEBITDA (CAD)
27 Q1-5.43M
26 Q4-7.1M
26 Q3-5.6M
26 Q2-4.86M
26 Q1-5.49M
25 Q4-5.7M
25 Q3-5.1M
25 Q2-5.52M
25 Q1-4.04M
24 Q4-4M
Cash Flows (CAD)
-6M-4M-2M024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDNA.TO Cash Flows (CAD) by quarter
PeriodCash Flows (CAD)
27 Q1-4.43M
26 Q40
26 Q3-4.96M
26 Q2-4.94M
26 Q1-3.55M
25 Q4-5M
25 Q3-3.56M
25 Q2-5.62M
25 Q1-2.36M
24 Q4-4.84M
EPS (CAD)
-0.2-0.100.124 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDNA.TO EPS (CAD) by quarter
PeriodEPS (CAD)
27 Q1-0.06
26 Q4-0.05
26 Q3-0.05
26 Q2-0.06
26 Q1-0.06
25 Q40.02
25 Q3-0.07
25 Q2-0.05
25 Q1-0.05
24 Q4-0.2
Expenses (CAD)
-5M05M10MR&DSG&ACapex24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDNA.TO Expenses (CAD) by quarter
PeriodExpenses (CAD)
27 Q15.43M
26 Q42.62M
26 Q3635K
26 Q25.45M
26 Q15.49M
25 Q45.7M
25 Q35.1M
25 Q25.52M
25 Q14.07M
24 Q44M
Cash & Debt (CAD)
010M20M30M40MCashLong Term DebtShort Term Debt24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDNA.TO Cash & Debt (CAD) by quarter
PeriodCash & Debt (CAD)
27 Q15.69M
26 Q46.25M
26 Q310.61M
26 Q215.75M
26 Q120.46M
25 Q424.84M
25 Q330M
25 Q230.43M
25 Q135.63M
24 Q416.98M
Debt ratios
00.511.5224 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDNA.TO Debt ratios by quarter
PeriodDebt ratios
27 Q10.24
26 Q40.27
26 Q30.48
26 Q20.74
26 Q10.93
25 Q41.21
25 Q31.6
25 Q21.65
25 Q11.95
24 Q40.91
Margins
0%50%100%150%25 Q1
MDNA.TO Margins by quarter
PeriodMargins
25 Q1100%
Return on Capital
-400%-300%-200%-100%0%100%24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDNA.TO Return on Capital by quarter
PeriodReturn on Capital
27 Q1-303.77%
26 Q4-170.59%
26 Q3-70.25%
26 Q2-47.68%
26 Q1-33.66%
25 Q46.22%
25 Q3-29.75%
25 Q2-20.77%
25 Q1-15.9%
24 Q4-267.85%
Shares Outstanding
025M50M75M100M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDNA.TO Shares Outstanding by quarter
PeriodShares Outstanding
27 Q186.64M
26 Q483.42M
26 Q383.42M
26 Q283.41M
26 Q182.52M
25 Q478.22M
25 Q378.01M
25 Q276.84M
25 Q173.62M
24 Q469.64M
Book Value Per Share (CAD)
00.10.20.30.424 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDNA.TO Book Value Per Share (CAD) by quarter
PeriodBook Value Per Share (CAD)
27 Q10.02
26 Q40.03
26 Q30.07
26 Q20.12
26 Q10.18
25 Q40.24
25 Q30.22
25 Q20.26
25 Q10.31
24 Q40.07
Total Assets (CAD)
010M20M30M40M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDNA.TO Total Assets (CAD) by quarter
PeriodTotal Assets (CAD)
27 Q18.25M
26 Q48.45M
26 Q313.06M
26 Q218.04M
26 Q122.77M
25 Q428.38M
25 Q332.24M
25 Q232.93M
25 Q138.02M
24 Q419.13M
Free Cash Flow Yield
-60%-40%-20%0%med -22.05%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
MDNA.TO Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-38.85%
Sep 26-34.3%
Aug 26-33.94%
Aug 26-39.32%
Aug 26-35.05%
Aug 26-42.99%
Jul 26-44.78%
Jul 26-46.06%
Jul 26-46.06%
Jul 26-43.57%
Jul 26-40.81%
Jun 26-54.6%
Jun 26-51.42%
Jun 26-52.65%
Jun 26-49.14%
May 26-52.03%
May 26-48.6%
May 26-40.95%
May 26-35.1%
May 26-36.25%
Apr 26-34.02%
Apr 26-36.25%
Apr 26-34.02%
Apr 26-35.66%
Mar 26-32.42%
Mar 26-29.17%
Mar 26-26.52%
Mar 26-24.91%
Feb 26-22.69%
Feb 26-22.69%
Feb 26-24.61%
Feb 26-24.91%
Jan 26-23.21%
Jan 26-21.73%
Jan 26-21.5%
Jan 26-21.73%
Jan 26-20.42%
Dec 25-22.83%
Dec 25-21.25%
Dec 25-19.51%
Dec 25-13.58%
Nov 25-13.41%
Nov 25-15.44%
Nov 25-15.11%
Nov 25-14.8%
Oct 25-14.5%
Oct 25-13.58%
Oct 25-23.85%
Oct 25-22.83%
Oct 25-21.68%
Sep 25-22.01%
Sep 25-21.13%
Sep 25-19.93%
Sep 25-20.12%
Aug 25-19.38%
Aug 25-19.21%
Aug 25-19.56%
Aug 25-17.75%
Aug 25-25.15%
Jul 25-25.15%
Jul 25-25.15%
Jul 25-25.15%
Jul 25-23.22%
Jun 25-25.29%
Jun 25-24.13%
Jun 25-23.32%
Jun 25-23.07%
May 25-22.09%
May 25-20.18%
May 25-18.58%
May 25-19.8%
May 25-19.99%
Apr 25-19.44%
Apr 25-19.08%
Apr 25-23.32%
Apr 25-23.32%
Mar 25-22.37%
Mar 25-21.92%
Mar 25-19.93%
Mar 25-22.14%
Feb 25-21.08%
Feb 25-19.06%
Feb 25-16.36%
Feb 25-17.26%
Jan 25-16.61%
Jan 25-16.36%
Jan 25-15.44%
Jan 25-16%
Jan 25-13.79%
Dec 24-11.9%
Dec 24-12.03%
Dec 24-11.63%
Dec 24-10.5%
Nov 24-11.96%
Nov 24-13.11%
Nov 24-14.19%
Nov 24-9.27%
Nov 24-8.2%
Oct 24-8.76%
Oct 24-9.03%
Price to Sales
10000200003000040000med 16977.65Oct 24Dec 24Feb 25Apr 25Jun 25Aug 25Sep 25
MDNA.TO Price to Sales by quarter
PeriodPrice to Sales
Sep 2515017.42
Sep 2515643.15
Sep 2516581.74
Sep 2516425.3
Aug 2517051.03
Aug 2517207.46
Aug 2516894.6
Aug 2518615.34
Aug 2513140.24
Jul 2513140.24
Jul 2513140.24
Jul 2513140.24
Jul 2514235.26
Jun 2512949.51
Jun 2513573.58
Jun 2514041.64
Jun 2514197.65
May 2514821.73
May 2516225.89
May 2517630.05
May 2516537.93
May 2516381.91
Apr 2516849.96
Apr 2517162
Apr 2514041.64
Apr 2514041.64
Mar 2515060.17
Mar 2515367.52
Mar 2516904.27
Mar 2515213.84
Feb 2515982.22
Feb 2517672.65
Feb 2520592.48
Feb 2519516.75
Jan 2520285.13
Jan 2520592.48
Jan 2521821.88
Jan 2521053.5
Jan 2524434.36
Dec 2425473.46
Dec 2425178.97
Dec 2426062.44
Dec 2428860.11
Nov 2425326.22
Nov 2423117.54
Nov 2421350.59
Nov 2432688.49
Nov 2436958.61
Oct 2434602.68
Oct 2433571.96
Oct 2432835.74
Oct 2432394
Price to Book
05101520med 5.67Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
MDNA.TO Price to Book by quarter
PeriodPrice to Book
Sep 2613.95
Sep 2615.8
Aug 2615.96
Aug 2613.78
Aug 2615.46
Aug 2612.6
Jul 2612.1
Jul 2611.76
Jul 2611.76
Jul 2612.44
Jul 2613.28
Jun 265.44
Jun 265.77
Jun 265.64
Jun 266.04
May 265.71
May 266.11
May 267.25
May 268.46
May 268.19
Apr 268.73
Apr 268.19
Apr 268.73
Apr 268.33
Mar 265.13
Mar 265.7
Mar 266.27
Mar 266.68
Feb 267.33
Feb 267.33
Feb 266.76
Feb 266.68
Jan 267.17
Jan 267.66
Jan 267.74
Jan 267.66
Jan 268.14
Dec 255.3
Dec 255.69
Dec 256.2
Dec 258.91
Nov 259.02
Nov 257.83
Nov 258
Nov 258.17
Oct 258.34
Oct 258.91
Oct 255.07
Oct 255.3
Oct 255.58
Sep 253.93
Sep 254.1
Sep 254.34
Sep 254.3
Aug 254.46
Aug 254.51
Aug 254.42
Aug 254.87
Aug 253.44
Jul 253.44
Jul 253.44
Jul 253.44
Jul 253.73
Jun 253.71
Jun 253.89
Jun 254.02
Jun 254.07
May 254.25
May 254.65
May 255.05
May 254.74
May 254.69
Apr 254.83
Apr 254.92
Apr 254.02
Apr 254.02
Mar 253.76
Mar 253.83
Mar 254.22
Mar 253.79
Feb 253.99
Feb 254.41
Feb 255.13
Feb 254.87
Jan 255.06
Jan 255.13
Jan 255.44
Jan 255.25
Jan 256.09
Dec 245.57
Dec 245.5
Dec 245.7
Dec 246.31
Nov 245.53
Nov 245.05
Nov 244.67
Nov 247.14
Nov 248.08
Oct 247.56
Oct 247.34
Medicenna Therapeutics Corp.
MDNA.TO
Stockpicker

Video analysis: MDNA.TO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.